De Young & Hayden, LLC is a consulting partnership that helps biopharmaceutical
executives make data-based decisions.

We help executives evaluate internal and external product opportunities by:

  • Creating in-depth, scientifically validated Target Product Profiles and development
    strategies to effectively manage portfolios
  • Interviewing Key Opinion Leaders (KOLs) to evaluate and understand critical issues
    through objective scientific expert opinion
  • Identifying specific go/no-go hurdles to enable informed decisions and establish
    objective criteria for continuing or ending a project
  • Developing successful research and development strategies
  • Strengthening internal and external communication to influence decision makers
    and expedite approvals

At every stage of development from preclinical planning through NDA filing and
marketing, we help maintain critical focus on the commercial success of the product.
Providing Expert Support to Biopharmaceutical Executives
Engaged in New Product Planning
 
 
 
This website Copyright 2007 De Young & Hayden, LLC.
The microscopic photograph of penicillin used in the banner is used courtesy of Tina (Weatherby) Carvalho,
MicroAngela.

    "Larry and Brad worked with us on due diligence projects including product
    evaluation. They provided the kind of information we needed to support our internal
    decision making process.  Due to Larry’s & Brad’s scientific, biopharmaceutical and
    therapeutic area expertise, this team required minimum briefing and guidance which
    allowed us to meet challenging project deadlines. Furthermore, we were also
    impressed with the top-level Key Opinion Leaders that they were able to bring to our
    projects.

    In summary, premium service at very reasonable cost."

    Christian Pangratz
    Director/Program Leader
    NEKTAR THERAPEUTICS